Corien L. Eckhardt

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A

Corien L. Eckhardt, Alice S. van Velzen, Marjolein Peters et al. · Blood · 2013 · 214 citations · Full text

Intensive peri-operative use of factor VIII and the Arg593→Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A

Corien L. Eckhardt, Laura Menke, C. Heleen van Ommen et al. · Journal of Thrombosis and Haemostasis · 2009 · 95 citations · Full text

Inflammation, Intensive Peri-operative Use, Inhibitor Development +7

Inhibitor development and mortality in non‐severe hemophilia A

Corien L. Eckhardt, J.I. Loomans, Alice S. van Velzen et al. · Journal of Thrombosis and Haemostasis · 2015 · 74 citations · Full text

Is gestational weight gain associated with offspring obesity at 36 months?

J. C. Diesel, Corien L. Eckhardt, Nancy L. Day et al. · Pediatric Obesity · 2014 · 50 citations · Full text

Intensity of factor VIII treatment and the development of inhibitors in non‐severe hemophilia A patients: results of the INSIGHT case–control study

Alice S. van Velzen, Corien L. Eckhardt, Marjolein Peters et al. · Journal of Thrombosis and Haemostasis · 2017 · 36 citations · Full text

Factor Viii Treatment, Hematology, Insight Case–control Study +6